The results indicated that the PRV program had a positive and statistically significant impact on the development of drugs for less common tropical diseases, but an only marginally significant impact on the number of malaria and tuberculosis development programs.
← all excerpts
Is the priority review voucher program stimulating new drug development for tropical diseases?
1
—
—